Abramsonc Cancer Center of the University of Pennsylvania is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Abramsonc Cancer Center of the University of Pennsylvania has participated in 2 clinical trials.
Therapeutic areas: Basal Cell Carcinoma, Squamous Cell Carcinoma, Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL.
Sponsors: Abramson Cancer Center at Penn Medicine, University of Pennsylvania.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramsonc Cancer Center of the University of Pennsylvania has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramsonc Cancer Center of the University of Pennsylvania has 2 clinical trials on record. Their work covers Basal Cell Carcinoma, Squamous Cell Carcinoma, Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL.
Abramsonc Cancer Center of the University of Pennsylvania has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.